64 employees
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
2019
$139M
from 3 investors over 3 rounds
Jaguar Gene Therapy raised undisclosed on March 29, 2022
Investors: JDRF T1D Fund
Jaguar Gene Therapy raised $139M on April 13, 2021
Investors: ARCH Venture Partners and Nolan Capital, Inc.